Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Morrissette, J. J.D.
Right arrow Articles by Spinner, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrissette, J. J.D.
Right arrow Articles by Spinner, N. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 4 405-413
© 2001 Oxford University Press

Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome

Jennifer J.D. Morrissette, Raymond P. Colliton and Nancy B. Spinner+

Division of Human Genetics and Molecular Biology, Children’s Hospital of Philadelphia, 1006 Abramson Research Center, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA

Jagged1 (JAG1) is a cell surface ligand in the Notch signaling pathway and mutations in this gene cause Alagille syndrome (AGS). JAG1 mutations have been identified in 60–70% of AGS patients studied, and these include total gene deletions (~6%), protein-truncating mutations (insertions, deletions and nonsense mutations) (82%) and missense mutations (12%). Based on the finding that total JAG1 deletions cause AGS, haploinsufficiency has been hypothesized to be a mechanism for disease causation; however, the mechanism by which missense mutations cause disease is not understood. To date, 25 unique missense mutations have been observed in AGS patients. Missense mutations are non-randomly distributed across the protein with clusters at the 5' end of the protein, in the conserved DSL domain, and two clusters within the EGF repeats. To understand the effect of the missense mutations on protein localization and function, we have studied four missense mutations (R184H, L37S, P163L and P871R). In two assays of JAG1 function, R184H and L37S are associated with loss of Notch signaling activity relative to wild-type JAG1. Neither R184H or L37S is present on the cell surface and both are abnormally glycosylated. Furthermore, these mutations lead to abnormal accumulation of the protein, possibly in the endoplasmic reticulum. Both P163L and P871R are associated with normal levels of Notch signaling activity and are present on the cell surface, consistent with these changes being polymorphisms rather than disease-causing mutations.

+ To whom correspondence should be addressed. Tel: +1 215 590 3316; Fax: +1 215 590 3850; Email: spinner@mail.med.upenn.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. B.-D. Ponio, C. Wright-Crosnier, M.-T. Groyer-Picard, C. Driancourt, I. Beau, M. Hadchouel, and M. Meunier-Rotival
Biological function of mutant forms of JAGGED1 proteins in Alagille syndrome: inhibitory effect on Notch signaling
Hum. Mol. Genet., November 15, 2007; 16(22): 2683 - 2692.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Haritunians, T Chow, R P J De Lange, J T Nichols, D Ghavimi, N Dorrani, D M St Clair, G Weinmaster, and C Schanen
Functional analysis of a recurrent missense mutation in Notch3 in CADASIL
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1242 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Trifonova, D. Small, D. Kacer, D. Kovalenko, V. Kolev, A. Mandinova, R. Soldi, L. Liaw, I. Prudovsky, and T. Maciag
The non-transmembrane form of Delta1 but not of jagged1 Induces normal migratory behavior accompanied by FGF receptor 1-dependent transformation
J. Biol. Chem., February 9, 2004; (2004) 300564200.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
T. Gridley
Notch signaling and inherited disease syndromes
Hum. Mol. Genet., April 2, 2003; 12(90001): R9 - 13.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
B. McCright, J. Lozier, and T. Gridley
A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency
Development, March 4, 2003; 129(4): 1075 - 1082.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. B. McElhinney, I. D. Krantz, L. Bason, D. A. Piccoli, K. M. Emerick, N. B. Spinner, and E. Goldmuntz
Analysis of Cardiovascular Phenotype and Genotype-Phenotype Correlation in Individuals With a JAG1 Mutation and/or Alagille Syndrome
Circulation, November 12, 2002; 106(20): 2567 - 2574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sasaki, S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino
The p53 Family Member Genes Are Involved in the Notch Signal Pathway
J. Biol. Chem., January 4, 2002; 277(1): 719 - 724.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Small, D. Kovalenko, D. Kacer, L. Liaw, M. Landriscina, C. Di Serio, I. Prudovsky, and T. Maciag
Soluble Jagged 1 Represses the Function of Its Transmembrane Form to Induce the Formation of the Src-dependent Chord-like Phenotype
J. Biol. Chem., August 17, 2001; 276(34): 32022 - 32030.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.